Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1992-03-19
1994-03-29
Rollins, John W.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424485, 514343, 514813, 514922, 514936, 514944, 514946, 514964, 514965, 514974, A61K 970, A61K 914, A61K 3144
Patent
active
052982572
ABSTRACT:
A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of nicotine to a solution of a solidifying or gel-forming agent or mixture thereof in a suitable solvent or mixture of solvents and mixing or heating the mixture thereby obtained so as to form the solid, semi-solid or mucilaginous medium. The preparation can be used in a method of treating withdrawal symptoms associated with smoking cessation and for combating the psychological dependence that occurs through frequent smoking.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3731683 (1973-05-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3877468 (1975-04-01), Lichtneckert
patent: 3901248 (1975-08-01), Lichtneckert
patent: 4060084 (1977-11-01), Chandrasekaran
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4336243 (1982-06-01), Sanvordeker
patent: 4592753 (1986-06-01), Panoz
patent: 4597961 (1986-07-01), Etscorn
patent: 4624665 (1986-11-01), Nuwayser
patent: 4665069 (1987-04-01), Rosenberg
patent: 4675009 (1987-06-01), Hymes et al.
patent: 4680172 (1987-07-01), Leeson
patent: 4687481 (1987-08-01), Nuwayser
patent: 4758434 (1988-07-01), Kydonieus
patent: 4821745 (1989-04-01), Rosen et al.
patent: 4822617 (1989-04-01), Panoz
patent: 4839174 (1989-06-01), Baker
patent: 4920989 (1990-05-01), Rose et al.
patent: 4946853 (1990-08-01), Bannon et al.
patent: 4953572 (1990-09-01), Rose et al.
patent: 5016652 (1991-05-01), Rose et al.
patent: 5135480 (1992-08-01), Bannon et al.
Chem. Abst. 11135036d-35037e, 1989.
Chem. Abst 189:134913c, 1988.
Chem. Abst 101:105621k, 1984.
Chem. Abst 102:1911882, 1985.
Buchdremer, G., & Tolle, R., "Nikotinabhangigkeit", (1987) Psychiatrie der Gegenwart, vol. III, Abhangigdait und Sucht (pp. 443-465), Berlin, Heidelberg, New York: Springer.
Rose, J. E., M. E. Jarvik & K. D. Rose, "Transdermal Administration of Nicotine", in Drug & Alcohol Dependence, 13 (1984) 209-213.
Rose, Jed E. et al., "Transdermal nicotine reduces cigarette craving & nicotine preference" (1985), in Clin. Pharmacol. Ther. 38:450-456.
Rose, Jed Ph.D, "Transdermal nicotine as a strategy for nicotine replacement" (1985), in The Pharmacologic Treatment of Tobacco.
Bents & Buchdremer, "Weaning from Smoking" (1987), Dtsch. Med, Wschr., 112: 559-564.
The Pharmacologic Treatment of Tobacco Dependence: Proceedings of the world Congress, Nov. 4-5, 1985.
The American Journal of Cardiology vol. 38, Aug. 1976 "Effect of Nitroglycerin Ointment on the Clinical and Hemodynamic Response to Exercise", John O. Parker, MD, FACC et al.
Aviation, Space & Environmental Medicine, Nov. 1979, "Effect of Transdermally Administered Scopolamine in Preventing Motion Sickness", M. E. McCauley et al.
Republic Scene, Nov. 1982, "Better Ways to Take Your Medicine", Dennis Meredith.
Schneider & Jarvik (1983) "Time Course of Smoking Withdrawal symptoms as a Function of Nicotine Replacement", Psychopharmacology (1984) 82: 143-144.
Jarvik, Glick & Nakamura (1970) "Inhibition of cigarette smoking by orally administered nicotine", Clin. Pharmacol. Ther. 11: 574-576.
Brantmark, Ohlin & Westling (1973) "Nicotine-Containing chewing gum as an anti-smoking aid", Psychopharmacologia (Berl.) 31: 191-200.
Ferno, Lichtneckert & Lundgren (1973) "A Substitute for Tobacco Smoking", Psychopharmacologia (Berl.) 31: 201-204.
Schneider, Popek, Jarvik & Shitz (1977), "The Use of Nicotine Gum During Cessation of Smoking", Am. J. Psychiatry 134: 439-440.
McNabb, Ebert & McCusker (1982), "Plasma Nicotine Levels Produced by chewing nicotine gum", JAMA 248: 865-868.
Jarvis, Raw, Russell & Feyerabend (1982), "Randomised controlled Trial of Nicotien Chewing-Gum", Br. Med. J. 285: 537-540.
Fagerstrom (1982), "A Comparison of Psychological & Pharmacological Treatment in Smoking Cessation", J. Behav. Med. 5: 343-351.
Henningfield, Miyasato & Jasinski (1983) "Cigarette Smokers self-Administer Intravenous Nicotine", Pharmacol. Biochem. Behav. 19: 887-890.
Schneider, Jarvik, Forsythe, Read, Elliott & Schweiger (1983), "Nicotine Gum In Smoking Cessation: A Placebo-controlled, Double-blind Trial", Addic. Behav. 8:253-261.
Hughes Hatsukami, Pickens, Krahn, Malin & Luknic (1984), "Effect of Nicotine on the Tobacco Withdrawal Syndrome", Psychopharmacology 83: 82-87.
Schneider, Jarvik & Forsythe (1984), "Nicotine versus placebo gum in the alleviation of withdrawal during smoking cessation", Addic. Behav. 9: 149-156.
Jarvik & Schneider (1984), "Degree of Addiction & Effectiveness of Nicotine Gum Therapy for Smoking", Am. J. Psychiatry 141: 790-791.
West, Jarvis, Russell, Carruthers, Feyerabend (1984), "Effect of nicotine replacement on the cigarette withdrawal Syndrome", Br. J. Addiction 79: 215-219.
NIDA Research Monograph #53 "Pharmacological Adjuncts in smoking Cessation" (1985).
Benowitz, Jacob & Savanapridi (1987), "Determinants of Nicotine Intake While Chewing Nicotine Ploabrilex Gum", clin. Pharmacol. Ther. 41: 467-473.
Sachs (1986), "Cigarette Smoking: Health Effects & Cessation strategies," Clinics in Geriatric Medicine 2: 337-362.
Bannon Yvonne B.
Corish John
Corrigan Owen I.
Geoghegan Edward J.
Masterson Joseph G.
Church Marla J.
Elan Transdermal Limited
Rollins John W.
LandOfFree
Method for the treatment of withdrawal symptoms associated with does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of withdrawal symptoms associated with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of withdrawal symptoms associated with will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-789905